Evaluation of Massage Therapy for Cancer Related Fatigue in Breast Cancer Survivors
NCT07917845, Not applicable, Not yet recruiting, Wake Forest University Health Sciences
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Evaluation of Massage Therapy for Cancer Related Fatigue in Breast Cancer Survivors | ClinicalTrials.gov |
| NCT number | NCT07917845 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 34 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Wake Forest University Health Sciences | ClinicalTrials.gov |
| Conditions | Breast Cancer, Fatigue in Cancer Survivors | ClinicalTrials.gov |
| Interventions | Massage therapy | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-05 | ClinicalTrials.gov |
Registered outcomes 2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Patient-Reported Fatigue Score | Twice weekly for 3 weeks, including baseline before massage therapy (pre-MT), and at 4 weeks post-massage therapy (post-MT) | The patient-reported fatigue score, obtained from the PROMIS F-SF 7b, is a continuous variable measured on a 5-point scale (1-5), where 1 indicates never, and 5 indicates always, with a 24-hour recall. The PROMIS F-SF 7b includes 7 items that assess the participant's fatigue intensity, frequency, and interference with daily activities. Item responses are summed to generate a raw score ranging from 7 to 35, with higher scores indicating greater fatigue severity. Raw scores will be converted to standardized PROMIS T scores using the official table, resulting in T-scores ranging from 31.0 to 81.4, with higher scores indicating greater fatigue severity. | ClinicalTrials.gov |
| Secondary | Objective fatigue score | Twice weekly for 3 weeks, including baseline before pre-MT, and at 4 weeks post-MT | The objective fatigue score, obtained from the six-minute walk test (6MWT), is a continuous variable measured in meters and serves as an objective measure of fatigue and physical performance. The score reflects the distance the participant can walk in six minutes, as assessed by a trained designee. Higher values indicate better physical performance and lower levels of objective fatigue. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)